We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAMA:NASDAQMama's Creations, Inc. Analysis

Data as of 2026-06-26 - not real-time

$19.47

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Mama's Creations is riding a wave of strong top‑line momentum, posting roughly 50% revenue growth and a 66% earnings surprise this quarter, while technical gauges show a bullish MACD and a price that is still climbing toward its recent high. However, the stock is deep in overbought territory and trades at a price far above its discounted cash‑flow estimate, suggesting limited upside in the near term. The company’s low beta and defensive consumer‑staples positioning temper the volatility, but the 30‑day price swings remain elevated, reflecting a market that is pricing both the growth narrative and valuation risk. Investors should weigh the earnings beat and product‑innovation pipeline against the stretched valuation and near‑term technical overextension before committing capital.
The upcoming investor conferences and new menu innovations provide a catalyst for continued revenue expansion, yet the current price level and lack of dividend return imply that a cautious, perhaps phased, approach is prudent.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but RSI in overbought zone
  • Price near recent resistance level
  • Recent earnings beat supporting momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained 50% revenue growth and expanding product line
  • Positive investor‑conference exposure and brand visibility
  • Defensive consumer‑staples sector cushioning downside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Valuation remains significantly above intrinsic DCF estimate
  • Strong cash generation but modest free‑cash‑flow conversion
  • Stable sector fundamentals offset by high price multiples

Key Metrics & Analysis

Financial Health

Revenue Growth49.70%
Profit Margin3.23%
P/E Ratio129.8
ROE14.93%
ROA8.46%
Debt/Equity24.74
P/B Ratio14.3
Op. Cash Flow$10.4M
Free Cash Flow$5.2M

Technical Analysis

TrendBullish
RSI77.5
Support$12.98
Resistance$20.18
MA 20$15.93
MA 50$14.91
MA 200$13.58
MACDBullish
VolumeStable
Fear & Greed Index87.96

Valuation

Fair Value$4.95
Target Price$22.00
Upside/Downside12.99%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.67
Volatility66.55%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.